Cytomegalovirus disease in patients with glomerular diseases treated by immunosuppressive treatment

Celebi Z. K., Calayoglu R., Yalci A. K., Akturk S., ŞENGÜL Ş., KUTLAY S., ...More

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.46, no.12, pp.2357-2360, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 46 Issue: 12
  • Publication Date: 2014
  • Doi Number: 10.1007/s11255-014-0849-0
  • Journal Name: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2357-2360
  • Keywords: Cytomegalovirus, Glomerulonephritis, Immunosuppressive treatment, Renal failure, KIDNEY-TRANSPLANT RECIPIENTS, RENAL-TRANSPLANTATION, CMV INFECTION, TURKEY, GLOMERULONEPHRITIS, SEROPREVALENCE, CLASSIFICATION, VALACYCLOVIR, PREVENTION, PREVALENCE
  • Ankara University Affiliated: Yes

Abstract

Cytomegalovirus (CMV) infection is an important complication in organ and bone marrow recipients as well as patients infected with HIV. Although screening and prophylaxis have been defined in these patients, there are few data about the frequency of CMV disease in glomerular diseases treated by immunosuppression.